Skip to Content

Notice

Importer of Controlled Substances Application: Cerilliant Corporation

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

ACTION:

Notice of application.

DATES:

Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before August 15, 2018. Such persons may also file a written request for a hearing on the application on or before August 15, 2018.

ADDRESSES:

Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152.

End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been delegated to the Assistant Administrator of the DEA Diversion Control Division (“Assistant Administrator”) pursuant to section 7 of 28 CFR part 0, appendix to subpart R.

In accordance with 21 CFR 1301.34(a), this is notice that on June 12, 2018, Cerilliant Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas 78665 applied to be registered as an importer of the following basic classes of controlled substances:

Controlled substanceDrug codeSchedule
3-Fluoro-N-methylcathinone (3-FMC)1233I
Cathinone1235I
Methcathinone1237I
4-Fluoro-N-methylcathinone (4-FMC)1238I
Pentedrone (α-methylaminovalerophenone)1246I
Mephedrone (4-Methyl-N-methylcathinone)1248I
4-Methyl-N-ethylcathinone (4-MEC)1249I
Naphyrone1258I
N-Ethylamphetamine1475I
N,N-Dimethylamphetamine1480I
Fenethylline1503I
Methaqualone2565I
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole)6250I
SR-18 (Also known as RCS-8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole)7008I
5-Fluoro-UR-144 and XLR11 [1-(5-Fluoropentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone7011I
AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide)7012I
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole)7019I
AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide)7023I
THJ-2201 [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone7024I
AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide7031I
ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide)7035I
APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide7048I
JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole)7081I
SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole7104I
JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole)7118I
JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole)7122I
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone7144I
JWH-073 (1-Butyl-3-(1-naphthoyl)indole)7173I
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole)7200I
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole)7201I
JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) indole)7203I
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate)7222I
5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate)7225I
Alpha-ethyltryptamine7249I
Ibogaine7260I
CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol)7297I
CP-47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol)7298I
Start Printed Page 32907
Lysergic acid diethylamide7315I
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7)7348I
Marihuana7360I
Parahexyl7374I
Mescaline7381I
2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C-T-2)7385I
3,4,5-Trimethoxyamphetamine7390I
4-Bromo-2,5-dimethoxyamphetamine7391I
4-Bromo-2,5-dimethoxyphenethylamine7392I
4-Methyl-2,5-dimethoxyamphetamine7395I
2,5-Dimethoxyamphetamine7396I
JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole)7398I
3,4-Methylenedioxyamphetamine7400I
5-Methoxy-3,4-methylenedioxyamphetamine7401I
N-Hydroxy-3,4-methylenedioxyamphetamine7402I
3,4-Methylenedioxy-N-ethylamphetamine7404I
3,4-Methylenedioxymethamphetamine7405I
4-Methoxyamphetamine7411I
5-Methoxy-N-N-dimethyltryptamine7431I
Alpha-methyltryptamine7432I
Bufotenine7433I
Diethyltryptamine7434I
Dimethyltryptamine7435I
Psilocybin7437I
Psilocyn7438I
5-Methoxy-N,N-diisopropyltryptamine7439I
N-Ethyl-1-phenylcyclohexylamine7455I
1-(1-Phenylcyclohexyl)pyrrolidine7458I
1-[1-(2-Thienyl)cyclohexyl]piperidine7470I
N-Benzylpiperazine7493I
4-Methyl-alphapyrrolidinopropiophenone (4-MePPP)7498I
2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C-D)7508I
2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E)7509I
2-(2,5-Dimethoxyphenyl) ethanamine (2C-H)7517I
2-(4-iodo-2,5-dimethoxyphenyl) ethanamine (2C-I)7518I
2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C)7519I
2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N)7521I
2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C-P)7524I
2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C-T-4)7532I
MDPV (3,4-Methylenedioxypyrovalerone)7535I
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25B-NBOMe)7536I
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C-NBOMe)7537I
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25I-NBOMe)7538I
Methylone (3,4-Methylenedioxy-N-methylcathinone)7540I
Butylone7541I
Pentylone7542I
alpha-pyrrolidinopentiophenone (α-PVP)7545I
alpha-pyrrolidinobutiophenone (α-PBP)7546I
AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole)7694I
Desomorphine9055I
Etorphine (except HCl)9056I
Codeine methylbromide9070I
Heroin9200I
Morphine-N-oxide9307I
Normorphine9313I
Pholcodine9314I
U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide)9547I
AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide))9551I
Acetylmethadol9601I
Allylprodine9602I
Alphacetylmethadol except levo-alphacetylmethadol9603I
Alphameprodine9604I
Alphamethadol9605I
Betacetylmethadol9607I
Betameprodine9608I
Betamethadol9609I
Betaprodine9611I
Dextromoramide9613I
Dipipanone9622I
Hydroxypethidine9627I
Noracymethadol9633I
Norlevorphanol9634I
Normethadone9635I
Racemoramide9645I
Start Printed Page 32908
Trimeperidine9646I
1-Methyl-4-phenyl-4-propionoxypiperidine9661I
Tilidine9750I
Para-Fluorofentanyl9812I
3-Methylfentanyl9813I
Alpha-methylfentanyl9814I
Acetyl-alpha-methylfentanyl9815I
Beta-hydroxyfentanyl9830I
Beta-hydroxy-3-methylfentanyl9831I
Alpha-methylthiofentanyl9832I
3-Methylthiofentanyl9833I
Thiofentanyl9835I
Methamphetamine1105II
Methylphenidate1724II
Amobarbital2125II
Pentobarbital2270II
Secobarbital2315II
Glutethimide2550II
Nabilone7379II
1-Phenylcyclohexylamine7460II
Phencyclidine7471II
Phenylacetone8501II
1-Piperidinocyclohexanecarbonitrile8603II
Alphaprodine9010II
Dihydrocodeine9120II
Ecgonine9180II
Ethylmorphine9190II
Levomethorphan9210II
Levorphanol9220II
Meperidine9230II
Dextropropoxyphene, bulk (non-dosage forms)9273II
Levo-alphacetylmethadol9648II
Noroxymorphone9668II
Racemethorphan9732II
Alfentanil9737II
Remifentanil9739II
Sufentanil9740II
Carfentanil9743II
Tapentadol9780II

The company plans to import small quantities of the listed controlled substances for the manufacture of analytical reference standards and distribution to their research and forensic customers.

Start Signature

Dated: July 10, 2018.

John J. Martin,

Assistant Administrator.

End Signature End Supplemental Information

[FR Doc. 2018-15139 Filed 7-13-18; 8:45 am]

BILLING CODE 4410-09-P